Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.
about
Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitroRetrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.The ins and outs of DNA fingerprinting the infectious fungiCandida dubliniensis: characteristics and identification.Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicansRandom amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens.Prevalence of Candida dubliniensis isolates in a yeast stock collectionRapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes.Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensisIdentification of Candida dubliniensis in a prospective study of patients in the United States.High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected womenRapid identification of Candida dubliniensis with commercial yeast identification systems.Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in IsraelEvaluation of phenotypic markers for selection and identification of Candida dubliniensis.Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis.Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.Virulence Factors and Anti Fungal Sensitivity Pattern of Candida Sp. Isolated from HIV and TB Patients.Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatumTyping Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individualsParity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.Typing Candida albicans oral isolates from healthy brazilian schoolchildren using multilocus enzyme electrophoresis reveals two highly polymorphic taxa.Coaggregation of Candida dubliniensis with Fusobacterium nucleatum.Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agarThe closely related species Candida albicans and Candida dubliniensis can mate.Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans.Evaluation of a rapid immunochromatographic assay for identification of Candida albicans and Candida dubliniensis.Amplification of the hyphal wall protein 1 gene to distinguish Candida albicans from Candida dubliniensis.
P2860
Q24671525-6D29F024-3BB5-4E9F-BC7C-4A80EBFF20FDQ30596962-04573D62-DAC9-43F8-BDC2-C8381093567AQ33555593-24E60AC9-3B37-441D-8D6C-A076A33646ABQ33655501-5BC223F0-1535-4253-B7DA-343FC241D66AQ33674167-600B8006-3133-4E5B-8CCA-E20CF46FB64DQ33676337-67912FCD-4F02-4E52-8AEC-DF65A92DFCD7Q33678015-D5BD4D98-63EE-4136-B2FA-407E76CBD73DQ33681054-B860602A-AEE6-4B81-8B48-D6C6F12456B7Q33694469-0DD65AFE-B0B3-4ED2-B4BF-534CA1975D5AQ33958617-400C32C0-1045-4DDE-8340-EF50E2760F4AQ33960136-FD1B36C9-CA22-4DEE-B204-78057B529D99Q33963510-A2B3ED9B-5FDF-40E9-8005-8D21C45E792EQ33964932-429DBE02-6B6C-4CAD-BE89-B0A914910157Q33966538-F66C9789-16A0-4B6E-9E33-6568F6BFE0ECQ33974582-B3FB4A7B-A254-4076-BC35-5E2D4EB83737Q34947163-53508974-1BC5-48A8-9C16-FFE7E28469B7Q35467162-60C13B1E-31B3-4BE0-ACB2-2014392C9E21Q35533049-55B84985-EC66-43C8-B0DD-64BA749D15C8Q35685429-59E964B4-E753-4D1F-8F66-F7E34E62A1D2Q36532735-49728544-164D-4444-B30C-3B003462C041Q36544040-2A54C30D-D963-4032-92FF-C25E7A4D60BFQ36546438-F3E42CEF-509E-432B-BBFF-5DE220C017BAQ37159804-10902540-A8DE-4330-812D-74F215DC312BQ39448775-9BF79915-3A28-4EDC-AB99-54BB6170E7DFQ39463018-65024CA1-E55A-4E59-B7BA-36E66CA1B47AQ39601440-654473E1-28C1-446C-B457-1EF907241DBBQ39735352-8C182724-9888-4C17-8262-F03F29E34C4AQ40284763-2C99CCC1-B028-41A3-BBA3-BAACFC0250E3Q41481757-F3D8D27C-A451-4F62-B331-79574D386A28
P2860
Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Cluster of oral atypical Candi ...... ncy virus-positive drug users.
@en
type
label
Cluster of oral atypical Candi ...... ncy virus-positive drug users.
@en
prefLabel
Cluster of oral atypical Candi ...... ncy virus-positive drug users.
@en
P2093
P2860
P1476
Cluster of oral atypical Candi ...... ency virus-positive drug users
@en
P2093
Boerlin-Petzold F
Durussel C
P2860
P304
P407
P50
P577
1995-05-01T00:00:00Z